ABT

2024Q1BMO

Abbott Laboratories primary · HEALTHCARE · MEDICAL DEVICES

Report 2024-04-17 · Fiscal end 2024-03-31 · Features as of 2024-04-16

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS0.95
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.9%
IV front—
P/C full—
P/C front—
Features as of2024-04-16

Run-up

Close—
Ret 5d-2.9%
Ret 10d-2.5%
Ret 20d-2.9%
Ret 30d-9.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
0.98Beat
Estimated EPS0.95
Actual revenue
10.0B
Surprise %+3.2%
Beat / missBeat
Beat streak 41
Beat streak 81

Reaction

1-day stock reaction-1.5%
Implied vs actual

Implied 2.9%Actual 1.5%

Gap reaction-1.5%
Day result-3.0%
Next-day upNo
Realized / IV0.52×

Post tape

Post 5d+0.9%
Post 10d+0.4%
Post volume12.0M
Vol ×10d2.46×
Vol ×20d2.07×
Post range4.2%